Segui
Markus Riester
Markus Riester
Novartis Institutes for Biomedical Research
Email verificata su novartis.com
Titolo
Citata da
Citata da
Anno
Specific effects of microRNAs on the plant transcriptome
R Schwab, JF Palatnik, M Riester, C Schommer, M Schmid, D Weigel
Developmental cell 8 (4), 517-527, 2005
17262005
Highly Specific Gene Silencing by Artificial MicroRNAs in Arabidopsis
R Schwab, S Ossowski, M Riester, N Warthmann, D Weigel
The Plant Cell 18 (5), 1121-1133, 2006
16932006
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ...
Nature medicine 24 (10), 1504-1506, 2018
5032018
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma
T Ozawa, M Riester, YK Cheng, JT Huse, M Squatrito, K Helmy, N Charles, ...
Cancer cell 26 (2), 288-300, 2014
4392014
JAK–STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response
M Kleppe, M Kwak, P Koppikar, M Riester, M Keller, L Bastian, T Hricik, ...
Cancer discovery 5 (3), 316-331, 2015
318*2015
Pharmacogenomic agreement between two cancer cell line data sets
Cancer Cell Line Encyclopedia Consortium, ...
Nature 528 (7580), 84-87, 2015
2932015
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer
M Riester, JM Taylor, A Feifer, T Koppie, JE Rosenberg, RJ Downey, ...
Clinical cancer research 18 (5), 1323-1333, 2012
2342012
Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
M Riester, W Wei, L Waldron, AC Culhane, L Trippa, E Oliva, S Kim, ...
Journal of the National Cancer Institute, dju048, 2014
2262014
Evolution of the cancer genome
O Podlaha, M Riester, S De, F Michor
Trends in Genetics 28 (4), 155-163, 2012
2152012
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome
BF Ganzfried, M Riester, B Haibe-Kains, T Risch, S Tyekucheva, I Jazic, ...
Database 2013, 2013
2102013
Molecular alterations and everolimus efficacy in human epidermal growth factor receptor 2–overexpressing metastatic breast cancers: combined exploratory biomarker analysis from …
F André, S Hurvitz, A Fasolo, LM Tseng, G Jerusalem, S Wilks, R O’Regan, ...
Journal of Clinical Oncology 34 (18), 2115-2124, 2016
1802016
PureCN: copy number calling and SNV classification using targeted short read sequencing
M Riester, AP Singh, AR Brannon, K Yu, CD Campbell, DY Chiang, ...
Source code for biology and medicine 11, 1-13, 2016
1452016
FRANz: reconstruction of wild multi-generation pedigrees
M Riester, PF Stadler, K Klemm
Bioinformatics 25 (16), 2134-2139, 2009
1392009
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
AL Grauel, B Nguyen, D Ruddy, T Laszewski, S Schwartz, J Chang, ...
Nature communications 11 (1), 6315, 2020
1382020
Aberration in DNA Methylation in B-Cell Lymphomas Has a Complex Origin and Increases with Disease Severity
S De, R Shaknovich, M Riester, O Elemento, H Geng, M Kormaksson, ...
PLoS genetics 9 (1), e1003137, 2013
1372013
Tracking the evolution of resistance to ALK tyrosine kinase inhibitors through longitudinal analysis of circulating tumor DNA
I Dagogo-Jack, AR Brannon, LA Ferris, CD Campbell, JJ Lin, KR Schultz, ...
JCO precision oncology 2, 1-14, 2018
1362018
Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer
L Waldron, B Haibe-Kains, AC Culhane, M Riester, J Ding, XV Wang, ...
Journal of the National Cancer Institute 106 (5), dju049, 2014
1282014
Cross-study validation for the assessment of prediction algorithms
C Bernau, M Riester, AL Boulesteix, G Parmigiani, C Huttenhower, ...
Bioinformatics 30 (12), i105-i112, 2014
1172014
Software for the integration of multiomics experiments in bioconductor
M Ramos, L Schiffer, A Re, R Azhar, A Basunia, C Rodriguez, T Chan, ...
Cancer research 77 (21), e39-e42, 2017
1082017
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
JJ Pitt, M Riester, Y Zheng, TF Yoshimatsu, A Sanni, O Oluwasola, ...
Nature communications 9 (1), 4181, 2018
1052018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20